EMEIS SA (EMEIS.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:EMEIS - FR001400NLM4 - Common Stock
13.86 EUR
+0.16 (+1.17%)
EMEIS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 28 industry peers in the Health Care Providers & Services industry. EMEIS may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, EMEIS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year EMEIS has reported negative net income.
EMEIS had a positive operating cash flow in the past year.
In multiple years EMEIS reported negative net income over the last 5 years.
Each year in the past 5 years EMEIS had a positive operating cash flow.
1.2 Ratios
EMEIS has a worse Return On Assets (-3.07%) than 89.29% of its industry peers.
EMEIS has a Return On Equity of -23.89%. This is amonst the worse of the industry: EMEIS underperforms 89.29% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.03%, EMEIS is doing worse than 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.07% | ||
| ROE | -23.89% | ||
| ROIC | 0.03% |
ROA(3y)-7.04%
ROA(5y)-3.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
EMEIS has a Operating Margin of 0.08%. This is amonst the worse of the industry: EMEIS underperforms 85.71% of its industry peers.
EMEIS's Operating Margin has declined in the last couple of years.
The Profit Margin and Gross Margin are not available for EMEIS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.08% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3Y-79.31%
OM growth 5Y-64.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EMEIS is destroying value.
The number of shares outstanding for EMEIS has been increased compared to 1 year ago.
The number of shares outstanding for EMEIS has been reduced compared to 5 years ago.
EMEIS has a worse debt/assets ratio than last year.
2.2 Solvency
EMEIS has an Altman-Z score of 0.63. This is a bad value and indicates that EMEIS is not financially healthy and even has some risk of bankruptcy.
EMEIS has a Altman-Z score of 0.63. This is in the lower half of the industry: EMEIS underperforms 78.57% of its industry peers.
The Debt to FCF ratio of EMEIS is 51.23, which is on the high side as it means it would take EMEIS, 51.23 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 51.23, EMEIS is not doing good in the industry: 67.86% of the companies in the same industry are doing better.
A Debt/Equity ratio of 4.80 is on the high side and indicates that EMEIS has dependencies on debt financing.
The Debt to Equity ratio of EMEIS (4.80) is worse than 82.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.8 | ||
| Debt/FCF | 51.23 | ||
| Altman-Z | 0.63 |
ROIC/WACC0.01
WACC4.72%
2.3 Liquidity
EMEIS has a Current Ratio of 0.62. This is a bad value and indicates that EMEIS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.62, EMEIS is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
A Quick Ratio of 0.62 indicates that EMEIS may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.62, EMEIS is doing worse than 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.62 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
EMEIS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -136.53%.
Looking at the last year, EMEIS shows a small growth in Revenue. The Revenue has grown by 6.30% in the last year.
Measured over the past years, EMEIS shows a quite strong growth in Revenue. The Revenue has been growing by 8.55% on average per year.
EPS 1Y (TTM)-136.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.96%
Revenue 1Y (TTM)6.3%
Revenue growth 3Y9.45%
Revenue growth 5Y8.55%
Sales Q2Q%4.92%
3.2 Future
Based on estimates for the next years, EMEIS will show a very strong growth in Earnings Per Share. The EPS will grow by 24.84% on average per year.
Based on estimates for the next years, EMEIS will show a small growth in Revenue. The Revenue will grow by 2.70% on average per year.
EPS Next Y32.82%
EPS Next 2Y26.37%
EPS Next 3Y25.57%
EPS Next 5Y24.84%
Revenue Next Year5.58%
Revenue Next 2Y4.44%
Revenue Next 3Y4.41%
Revenue Next 5Y2.7%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
EMEIS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EMEIS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
82.14% of the companies in the same industry are cheaper than EMEIS, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EMEIS indicates a somewhat cheap valuation: EMEIS is cheaper than 60.71% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.83 | ||
| EV/EBITDA | 22.34 |
4.3 Compensation for Growth
A more expensive valuation may be justified as EMEIS's earnings are expected to grow with 25.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.37%
EPS Next 3Y25.57%
5. Dividend
5.1 Amount
EMEIS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EPA:EMEIS (12/29/2025, 4:12:01 PM)
13.86
+0.16 (+1.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners59.04%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap2.24B
Revenue(TTM)5.77B
Net Income(TTM)-412.06M
Analysts75.38
Price Target13.97 (0.79%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.79%
PT rev (3m)13.22%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)6.41%
EPS NY rev (3m)11.52%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.69%
Revenue NY rev (3m)0.79%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.4 | ||
| P/FCF | 12.83 | ||
| P/OCF | 4.74 | ||
| P/B | 1.3 | ||
| P/tB | N/A | ||
| EV/EBITDA | 22.34 |
EPS(TTM)-1.8
EYN/A
EPS(NY)-0.9
Fwd EYN/A
FCF(TTM)1.08
FCFY7.8%
OCF(TTM)2.92
OCFY21.1%
SpS34.91
BVpS10.68
TBVpS-7.69
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.07% | ||
| ROE | -23.89% | ||
| ROCE | 0.04% | ||
| ROIC | 0.03% | ||
| ROICexc | 0.03% | ||
| ROICexgc | 0.04% | ||
| OM | 0.08% | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | 3.1% |
ROA(3y)-7.04%
ROA(5y)-3.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-77.23%
ROICexgc growth 5Y-61.49%
ROICexc growth 3Y-76.08%
ROICexc growth 5Y-60.94%
OM growth 3Y-79.31%
OM growth 5Y-64.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.8 | ||
| Debt/FCF | 51.23 | ||
| Debt/EBITDA | 17.9 | ||
| Cap/Depr | 64.95% | ||
| Cap/Sales | 5.28% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 102.08% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.62 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 0.63 |
F-Score4
WACC4.72%
ROIC/WACC0.01
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)5.82%
Cap/Sales(5y)13.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.96%
EPS Next Y32.82%
EPS Next 2Y26.37%
EPS Next 3Y25.57%
EPS Next 5Y24.84%
Revenue 1Y (TTM)6.3%
Revenue growth 3Y9.45%
Revenue growth 5Y8.55%
Sales Q2Q%4.92%
Revenue Next Year5.58%
Revenue Next 2Y4.44%
Revenue Next 3Y4.41%
Revenue Next 5Y2.7%
EBIT growth 1Y103.51%
EBIT growth 3Y-77.35%
EBIT growth 5Y-61.53%
EBIT Next Year10752.2%
EBIT Next 3Y414.89%
EBIT Next 5Y255.33%
FCF growth 1Y293.3%
FCF growth 3YN/A
FCF growth 5Y14.58%
OCF growth 1Y28.92%
OCF growth 3Y-14.44%
OCF growth 5Y-10.16%
EMEIS SA / EMEIS.PA FAQ
What is the ChartMill fundamental rating of EMEIS SA (EMEIS.PA) stock?
ChartMill assigns a fundamental rating of 1 / 10 to EMEIS.PA.
What is the valuation status for EMEIS stock?
ChartMill assigns a valuation rating of 2 / 10 to EMEIS SA (EMEIS.PA). This can be considered as Overvalued.
What is the profitability of EMEIS stock?
EMEIS SA (EMEIS.PA) has a profitability rating of 1 / 10.
Can you provide the financial health for EMEIS stock?
The financial health rating of EMEIS SA (EMEIS.PA) is 0 / 10.
Can you provide the dividend sustainability for EMEIS stock?
The dividend rating of EMEIS SA (EMEIS.PA) is 0 / 10 and the dividend payout ratio is 0%.